Xu Zhenyu 4

What Happened
Zhenyu Xu, Chief Scientific Officer of SOPHiA GENETICS (SOPH), sold a total of 4,736 shares in two open-market transactions to satisfy tax withholding related to recent restricted stock unit (RSU) vesting. On 2026-04-08 he sold 2,800 shares at an average price of $4.84 for $13,549, and on 2026-04-09 he sold 1,936 shares at an average price of $4.74 for $9,176 (aggregate proceeds ≈ $22,725). These were sales (not purchases) and were executed pursuant to a pre-established Rule 10b5-1 plan.

Key Details

• Transaction dates and reported prices:
  • 2026-04-08: 2,800 shares sold at $4.84 each (reported value $13,549). (Price range for related trades: $4.79–$4.92; details available on request.)
  • 2026-04-09: 1,936 shares sold at $4.74 each (reported value $9,176). (Reported weighted-average price; executed in multiple trades at prices ranging $4.61–$4.87; details available on request.)
• Total shares sold: 4,736; total reported proceeds ≈ $22,725.
• Purpose: Sales were made to satisfy tax withholding obligations from RSU vestings on April 2 and 3, 2026, and were effected under a pre-established Rule 10b5-1 trading plan (non‑discretionary).
• Shares owned after the transactions: Not specified in this filing.
• Filing timeliness: Reported on 2026-04-10 for transactions on 2026-04-08 and 2026-04-09 — the Form 4 appears to be timely (not marked late).

Context
These sales were tax-withholding dispositions tied to RSU vesting and executed under a 10b5-1 plan, which are routine and typically do not signal a change in the insider's view of the company. Retail investors generally place more informational weight on insider purchases; routine withholding sales like these are common after equity vesting events.